Abiopharma

New Form 4 - DYNATRONICS CORP Filed: 2025-07-02 AccNo: 0001062993-25-012414 Size: 4 KB

New Form 6-K - GSK plc Filed: 2025-07-02 AccNo: 0001654954-25-007648 Size: 2 MB

New Form 4 - DYNATRONICS CORP Filed: 2025-07-02 AccNo: 0001062993-25-012412 Size: 6 KB

New Form 4 - DYNATRONICS CORP Filed: 2025-07-02 AccNo: 0001062993-25-012410 Size: 4 KB

New Form 8-K - Vaxart, Inc. Filed: 2025-07-02 AccNo: 0001437749-25-021865 Size: 168 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 8-K - ABEONA THERAPEUTICS INC. Filed: 2025-07-02 AccNo: 0001641172-25-017460 Size: 257 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - LIGAND PHARMACEUTICALS INC Filed: 2025-07-02 AccNo: 0000886163-25-000042 Size: 193 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Invivyd, Inc. Filed: 2025-07-02 AccNo: 0000950170-25-092528 Size: 342 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Tonix Pharmaceuticals Holding Corp. Filed: 2025-07-02 AccNo: 0001999371-25-008651 Size: 238 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Astrana Health, Inc. Filed: 2025-07-02 AccNo: 0001104659-25-065009 Size: 243 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits